Literature DB >> 10971515

Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions.

V Godot1, S Harraga, I Beurton, M Deschaseaux, E Sarciron, B Gottstein, D A Vuitton.   

Abstract

To clarify the role of Th1- and Th2-type cytokines in the various outcomes of human alveolar echinococcosis (AE), the cytokine immune response of self-cured patients was studied and compared with those of progressive AE patients and healthy subjects. Self-cured patients were divided into two groups according to the following clinical features: subjects who had positive Echinococcus multilocularis serologies and hepatic calcifications typical of AE were classified as 'abortive AE' patients, and those who had positive E. multilocularis serologies but no hepatic lesions or calcifications detectable by ultrasonography were classified as 'positive serology' subjects. Secretions of IL-5, IL-10 and interferon-gamma, and expression of IL-5 mRNA were evaluated in peripheral blood mononuclear cells (PBMC) stimulated in vitro with the mitogen phytohaemagglutinin-C or specific E. multilocularis antigenic preparations. The cytokine profile of abortive AE patients was the opposite of that observed in progressive AE patients. An intermediate profile was observed in positive serology subjects. PBMC from abortive AE patients, whether non-stimulated or stimulated with PHA and antigenic preparations, secreted significantly lower levels of IL-10 than those isolated from progressive AE patients. Our observations seem to confirm the regulatory role of IL-10 in the immunopathology of human AE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971515      PMCID: PMC1905721          DOI: 10.1046/j.1365-2249.2000.01308.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Alveolar echinococcosis.

Authors:  S Bresson-Hadni; I Beurton; B Bartholomot; D A Vuitton; P Kern; G Mantion; J P Miguet
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

2.  Sero-epidemiological survey for alveolar echinococcosis (by Em2-ELISA) of blood donors in an endemic area of Switzerland.

Authors:  B Gottstein; C Lengeler; P Bachmann; P Hagemann; P Kocher; M Brossard; F Witassek; J Eckert
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

3.  Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis.

Authors:  D A Vuitton; S Bresson-Hadni; L Laroche; D Kaiserlian; S Guerret-Stocker; J L Bresson; M Gillet
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

4.  Clinical efficacy of and immunologic alterations caused by interferon gamma therapy for alveolar echinococcosis.

Authors:  L Jenne; J Kilwinski; P Radloff; W Flick; P Kern
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

5.  Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report.

Authors:  M Schmid; H Samonigg; H Stöger; H Auer; M H Sternthal; M Wilders-Truschnig; E C Reisinger
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

6.  Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis (infection with Echinococcus multilocularis).

Authors:  B Gottstein; B Mesarina; I Tanner; R W Ammann; J F Wilson; J Eckert; A Lanier
Journal:  Am J Trop Med Hyg       Date:  1991-12       Impact factor: 2.345

7.  Serological differentiation between Echinococcus granulosus and E. multilocularis infections in man.

Authors:  B Gottstein; J Eckert; H Fey
Journal:  Z Parasitenkd       Date:  1983

8.  Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.

Authors:  D Sturm; J Menzel; B Gottstein; P Kern
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Determination of parasite-specific immunoglobulins using the ELISA in patients with echinococcosis treated with mebendazole.

Authors:  B Gottstein; J Eckert; W Woodtli
Journal:  Z Parasitenkd       Date:  1984

10.  Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis.

Authors:  S Bresson-Hadni; J J Laplante; D Lenys; P Rohmer; B Gottstein; P Jacquier; P Mercet; J P Meyer; J P Miguet; D A Vuitton
Journal:  Am J Trop Med Hyg       Date:  1994-12       Impact factor: 2.345

View more
  19 in total

1.  Molecular characterization of antigen B2 subunit in two genotypes of Echinococcus granulosus from Indian bubaline isolates, its stage specific expression and serological evaluation.

Authors:  D Pan; A K Bera; S Bandyopadhyay; S Das; T Rana; S K Das; S Bandyopadhyay; B Manna; D Bhattacharya
Journal:  Mol Biol Rep       Date:  2010-09-18       Impact factor: 2.316

2.  Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.

Authors:  M P Hübner; B J Manfras; M C Margos; D Eiffler; W H Hoffmann; H Schulz-Key; P Kern; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

4.  Major carbohydrate antigen of Echinococcus multilocularis induces an immunoglobulin G response independent of alphabeta+ CD4+ T cells.

Authors:  W J Dai; A Hemphill; A Waldvogel; K Ingold; P Deplazes; H Mossmann; B Gottstein
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 5.  Hepatic echinococcosis: clinical and therapeutic aspects.

Authors:  Giuseppe Nunnari; Marilia R Pinzone; Salvatore Gruttadauria; Benedetto M Celesia; Giordano Madeddu; Giulia Malaguarnera; Piero Pavone; Alessandro Cappellani; Bruno Cacopardo
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

6.  Plasma IL-23 and IL-5 as surrogate markers of lesion metabolic activity in patients with hepatic alveolar echinococcosis.

Authors:  Tuerhongjiang Tuxun; Shadike Apaer; Hai-Zhang Ma; Jin-Ming Zhao; Ren-Yong Lin; Tuerganaili Aji; Ying-Mei Shao; Hao Wen
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

7.  Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.

Authors:  V Godot; S Harraga; I Beurton; P Tiberghien; E Sarciron; B Gottstein; D A Vuitton
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 8.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

Review 9.  Echinococcosis and allergy.

Authors:  Dominique A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

Review 10.  Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern.

Authors:  Johannes Eckert; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.